Ticker
ANABCompany Name
ANAPTYSBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Enterprise Value | Enterprise Value over Free Cash Flow | Free Cash Flow |
---|---|---|---|
6/30/2025 | $ 933.21M | 0 | $ -128.08M |
3/31/2025 | $ 856.38M | 0 | $ -109.15M |
12/31/2024 | $ 749.32M | 0 | $ -135.69M |
9/30/2024 | $ 780.4M | 0 | $ -103.39M |
6/30/2024 | $ 1.2B | 0 | $ -129.9M |
3/31/2024 | $ 990.45M | 0 | $ -134.14M |
12/31/2023 | $ 917.57M | 0 | $ -121.61M |
9/30/2023 | $ 733.73M | 0 | $ -97.84M |
6/30/2023 | $ 783.55M | 0 | $ -79M |
3/31/2023 | $ 781.89M | 0 | $ -77.63M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EV / FCF
(=) EV/FCF
EV/FCF for ANAPTYSBIO INC is calculated as follows: EV [ $ 601.1M ] / FCF [ $ -67.9M ]
(=) EV/FCF [ 0 ]
Minimum
Sep 30, 2021
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 2.2K |
---|---|
min | 0.05 |
max | 77.98 |
average | 23.46 |
median | 19.08 |
std | 16.15 |